Smith & Nephew

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Smith & Nephew and other ETFs, options, and stocks.

About SNN

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. 

CEO
Deepak S Nath
CEODeepak S Nath
Employees
18,362
Employees18,362
Headquarters
Watford, Herefordshire
HeadquartersWatford, Herefordshire
Founded
1856
Founded1856
Employees
18,362
Employees18,362

SNN Key Statistics

Market cap
12.16B
Market cap12.16B
Price-Earnings ratio
18.82
Price-Earnings ratio18.82
Dividend yield
2.70%
Dividend yield2.70%
Average volume
1.26M
Average volume1.26M
High today
$29.38
High today$29.38
Low today
$29.06
Low today$29.06
Open price
$29.22
Open price$29.22
Volume
431.02K
Volume431.02K
52 Week high
$37.51
52 Week high$37.51
52 Week low
$26.12
52 Week low$26.12

SNN News

Simply Wall St 1d
Why Smith & Nephew Is Back In The Spotlight - Simply Wall Street

...

Why Smith & Nephew Is Back In The Spotlight - Simply Wall Street
TipRanks 3d
Smith & Nephew: Neutral Stance Maintained With Unchanged 1,100 GBp Price Target Amid Reset Phase and Knee Segment Challenges

In a report released today, Julien Ouaddour from Bank of America Securities reiterated a Hold rating on Smith & Nephew, with a price target of p1,100.00. Julien...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.